Daffodills Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Meerut, Uttar Pradesh, India, established in 1985.
1985 Meerut, Uttar Pradesh, India Active
Last Updated:
Access Report
About Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited, a active public limited company, was established on 28 May 1985 in Meerut, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233UP1985PLC007205. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.23 Cr.

Formerly known as Daffodills Pharmaceutical Private Limited. It upholds a compliant status. Employing 11 professional, Its leadership includes Pranav Chaudhary (Director), Prateek Chaudhary (Director), Prabhat Kumar Rai (Whole-Time Director). Past directors included Amit Dhaka, Narender Chaudhary, Surender Chaudhary. It holds ₹16.93 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, 250001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP1985PLC007205

  • Registration Number

    007205

  • Incorporation Date

    28 May 1985

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹3.23 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 3.23 Cr
  • Company Age 40 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 16.93 Cr
  • Revenue Growth **** 31.92%
  • Profit Growth **** 11.89%
  • Ebitda **** -29.69%
  • Net Worth 5.89%
  • Total Assets **** 19.45%
Company report

Daffodills Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Daffodills Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daffodills Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Pranav Chaudhary Director 22 Feb 2012 Current
Prateek Chaudhary Director 22 Feb 2012 Current
Prabhat Kumar Rai Whole-Time Director 30 Jul 2019 Current
Kunwar Krishanpal Singh Whole-Time Director 30 Jul 2019 Current
Prashant Chaudhry Director 02 Aug 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Sep 2018 Past
Pramod Abcsdd Director 23 Feb 2012 Past
Pramod Abcsdd Director 23 Feb 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daffodills Pharmaceuticals.

Daffodills Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.92% increase. The company also saw a substantial improvement in profitability, with a 11.89% increase in profit. The company's net worth moved up by a moderate rise of 5.89%.

Daffodills Pharmaceuticals revenue growth over time
Daffodills Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 31.92%
*******
*******
*******
*******
Revenue from Operations
*******
 32.91%
*******
*******
*******
*******
Total Assets
*******
 19.45%
*******
*******
*******
*******
Profit or Loss
*******
 11.89%
*******
*******
*******
*******
Net Worth
*******
 5.89%
*******
*******
*******
*******
EBITDA
*******
 -29.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daffodills Pharmaceuticals?

In 2023, Daffodills Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹169,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 9.60 Cr
  • State Bank Of India : 6.95 Cr
  • U. P. Financial Corporation : 0.38 Cr
Latest Charge Details
Date Lender Amount Status
03 Oct 2025 State Bank Of India ₹6.95 Cr Open
26 May 2025 Axis Bank Limited ₹4.60 Cr Open
20 Sep 2018 Axis Bank Limited ₹5.00 Cr Open
14 Oct 1995 U. P. Financial Corporation ₹3.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Daffodills Pharmaceuticals?

Daffodills Pharmaceuticals has a workforce of 11 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daffodills Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodills Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daffodills Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 6.95 Cr with Charge ID 101161572 was registered on 03 Oct 2025. was documented.

  • Annual General Meeting

    Progress on Daffodills Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 4.60 Cr with Charge ID 101120639 was registered on 26 May 2025. was documented.

  • Balance Sheet

    The activity Daffodills Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    Progress on Prabhat Kumar Rai was appointed as a Whole-time director was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 6 years 7 months . was documented.

  • Director Appointment

    Progress on Kunwar Krishanpal Singh was appointed as a Whole-time director was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 6 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daffodills Pharmaceuticals Limited?

The CIN of Daffodills Pharmaceuticals Limited is U24233UP1985PLC007205.

Where is Daffodills Pharmaceuticals Limited headquartered?

Daffodills Pharmaceuticals Limited is headquartered at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, 250001.

When was Daffodills Pharmaceuticals Limited incorporated?

Daffodills Pharmaceuticals Limited was incorporated on 28 May 1985.

Who are the current directors of Daffodills Pharmaceuticals Limited?

The current directors of Daffodills Pharmaceuticals Limited are

What is the primary industry of Daffodills Pharmaceuticals Limited?

The primary industry of Daffodills Pharmaceuticals Limited is Manufacturing.

Is Daffodills Pharmaceuticals Limited a listed company?

Daffodills Pharmaceuticals Limited is unlisted.

What is the capital structure of Daffodills Pharmaceuticals Limited?

The authorized capital of Daffodills Pharmaceuticals Limited is ₹5.50 Cr, and the paid-up capital is ₹3.23 Cr.

What is the compliance status of Daffodills Pharmaceuticals Limited?

The compliance status of Daffodills Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available